Novel Pharmacotherapies for Diabetic Macular Edema (DME)

This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. Diabetic macular edema (DME) is the leading cause of vision loss in diabetic patients and is characterized by increased intraocular pressure and abnormal vessel growth in retinal area. Hyperglycemia in diabetes leads to up-regulation of inflammatory factors, and induces the breakdown of the blood-retinal barrier and fluid accumulation, ultimately causing macular swelling. This figure provides an overview of novel therapeutic strategies targeting different signaling pathways involved in the pathogenesis of DME.

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.